Bank of America reduced its price target on Envision healthcare from $72 to $60 earlier this week, according to Dispatch Tribunal.
Here are four key points:
1. The firm has a "buy" rating on Envision shares.
2. On Aug. 24, Jefferies set a $71 price target on Envision shares.
3. Envision shares have a 50-day moving average of $46.95 and 200-day moving average of $54.97.
4. The company's market cap is $4.88 billion.